Professional Documents
Culture Documents
Biochemistry - METABOLISM OF PROTEIN
Biochemistry - METABOLISM OF PROTEIN
Biochemistry - METABOLISM OF PROTEIN
PROTEIN METABOLISM(incomplete)
Phenylketonuria- An overview
Explain why phenylketonurics are warned against eating products containing the artificial
sweetener aspartame (Nutrasweet; chemical name L-Aspartyl-L-Phenylalanine methyl ester)?
Discuss the biochemical defect, clinical manifestations, laboratory diagnosis and treatment of
Phenylketonuria.
Aspartame contains Aspartic acid and phenyl alanine. The patients suffering from Phenylketonuria
have high levels of phenyl alanine, any further increase in phenylalanine can prove harmful to the
patient.
(See the details below )
Phenylketonuria (PKU)
Phenylketonuria (PKU) is an inherited error of metabolism caused by deficiency of the enzyme
phenylalanine hydroxylase. Loss of this enzyme results in mental retardation, organ damage, and
unusual posture and can, in cases of maternal PKU, result in severely compromised pregnancy.
Incidence
Classic PKU and the other causes of hyperphenylalaninemia affect about one of every 10,000 to
20,000 Caucasian or Oriental births. The incidence in African Americans is far less. These disorders
are equally frequent in males and females.
Biochemical defect
Deficiency of the enzyme phenylalanine hydroxylase or of its cofactor (Figure-1) causes
accumulation of phenylalanine in body fluids and the central nervous system (CNS).
Figure-1- showing the conversion of phenyl alanine to Tyrosine. The reaction is catalyzed by phenyl
alanine hydroxylase . The enzyme requires tetrahydrobiopterine as a cofactor.
Overview of Phenyl alanine metabolism –Phenyl alanine is metabolized through formation of
Tyrosine. The first enzyme in the catabolic pathway for phenylalanine (Figure-1 and
2), phenylalanine hydroxylase, catalyzes the hydroxylation of phenylalanine to tyrosine.
Phenylalanine hydroxylase inserts one of the two oxygen atoms of O 2 into phenylalanine to form
the hydroxyl group of tyrosine; the other oxygen atom is reduced to H 2O by the NADH/NADPH also
required in the reaction. This is one of a general class of reactions catalyzed by enzymes
called mixed-function oxidases , all of which catalyze simultaneous hydroxylation of a substrate by
O2 and reduction of the other oxygen atom of O 2 to H2O. Phenylalanine hydroxylase requires a
cofactor,tetrahydrobiopterin, which carries electrons from NADH/NADPH to O 2 in the hydroxylation
of phenylalanine. During the hydroxylation reaction the coenzyme is oxidized to dihydrobiopterin
(Figure-2). It is subsequently reduced again by the enzyme dihydrobiopterin reductase in a reaction
that requires NADH/NADPH.
Figure-3- Alternative pathways for catabolism of phenylalanine in phenylketonurics. Phenylpyruvate
accumulates in the tissues, blood, and urine. Phenylacetate and phenyllactate can also be found in
the urine.
Clinical manifestations
CLASSICAL PKU
The affected infant is normal at birth.
Mental retardation may develop gradually and may not be evident for the first few months.
It is usually severe, and most patients require institutional care if the condition remains
untreated. Mental retardation is due to direst toxic effect of phenyl alanine as well as due to
impaired formation of catecholamines .
Vomiting, sometimes severe enough to be misdiagnosed as pyloric stenosis, may be an
early symptom.
Older untreated children become hyperactive with purposeless movements, rhythmic
rocking, and athetosis.
On physical examination these infants are fairer in their complexion (Figure-5) than
unaffected siblings. There is impaired formation of melanin, since tyrosine is a precursor of
melanin (Figure-4).
Some may have a seborrheic or eczematous rash, which is usually mild and disappears as
the child grows older.
These children have an unpleasant odor of phenyl acetic acid, which has been described
as musty or mousy.
There are no consistent findings on neurologic examination. However, most infants
are hypertonic with hyperactive deep tendon reflexes.
About 25% of children have seizures, and more than 50%
have electroencephalographic abnormalities.
Microcephaly, prominent maxilla with widely spaced teeth, enamel hypoplasia, and growth
retardation are other common findings in untreated children.
Figure-4- showing the metabolic role of tyrosine. There is impaired formation of melanin and
catecholamines , manifested by blond hair, lighter skin and mental retardation.
MILDER FORMS OF PKU
1.Non-PKU Hyperphenylalaninemia.
In any screening program for PKU, a group of infants are identified in whom initial plasma
concentrations of phenylalanine are above normal (2mg/dL, 120µM) but less
than 20mg/dL (1200µM). These infants do not excrete phenylketones. Clinically, these infants may
remain asymptomatic but progressive brain damage may occur gradually with age. These patients
have milder deficiencies of phenylalanine hydroxylase or its cofactor tetrahydrobiopterin(BH4) than
those with classic PKU.
2.Hyperphenylalaninemia from Deficiency of the Cofactor Tetrahydrobiopterin (BH4)-
In 1–2% of infants with hyperphenylalaninemia, the defect resides in one of the enzymes
necessary for production or recycling of the cofactor BH4 .These infants are diagnosed as having
PKU, but they deteriorate neurologically despite adequate control of plasma phenylalanine. BH4 is
the cofactor for phenylalanine, tyrosine, and Tryptophan hydroxylase. The latter two hydroxylase are
essential for biosynthesis of the neurotransmitters dopamine and serotonin.
Plasma phenylalanine levels may be as high as those in classic PKU or in the range of milder forms
of hyperphenylalaninemia. Neurologic manifestations, such as loss of head
control, truncal hypotonia (floppy baby), drooling, swallowing difficulties, and myoclonic seizures,
develop after 3 months of age despite adequate dietary therapy.
3. Maternal Phenylketonuria
A number of women with Phenylketonuria who have been treated since infancy will reach
adulthood and become pregnant. If maternal phenylalanine levels are not strictly controlled before
and during pregnancy, their offspring are at increased risk for congenital defects and Microcephaly.
After birth, these children have severe mental and growth retardation. Pregnancy risks can be
minimized by continuing lifelong phenylalanine-restricted diets and assuring strict phenylalanine
restriction 2 months prior to conception and throughout gestation.
Figure-5- showing blond hair and eczematous rashes in a child suffering from PKU
DIAGNOSIS
Because of gradual development of clinical manifestations of hyperphenylalaninemia, early
diagnosis can only be achieved by mass screening of all newborn infants.
NEONATAL SCREENING FOR HYPERPHENYLALANINEMIA
The bacterial inhibition assay of Guthrie,(Figure-6) which was the first and still the most
widely used method for the purpose, is being replaced by more precise and quantitative
methods (fluorometric and tandem mass spectrometry).
Blood phenylalanine in affected infants with PKU may rise to diagnostic levels as early
as 4hr after birth even in the absence of protein feeding. It is recommended, however, that
the blood for screening be obtained in the first 24–48hr of life after feeding protein to
reduce the possibility of false-negative results, especially in the milder forms of the
condition
Plasma Phenyl Alanine levels In infants with positive results from the screen
for hyperphenylalaninemia, diagnosis should be confirmed by quantitative measurement of
plasma phenylalanine . A normal blood phenylalanine level is about 1 mg/dl. In classic
PKU, levels may range from 6 to 80mg/dl, but are usually greater than 30mg/dl. Levels are
somewhat less in the other disorders of hyperphenylalaninemia. .
Identification and measurement of phenylketones in the urine has no place in any
screening program. However, in countries and places where such programs are not in
effect, identification of phenylketones in the urine by ferric chloride may offer a simple test
for diagnosis of infants with developmental and neurologic abnormalities.
Once the diagnosis of hyperphenylalaninemia is established, deficiency of cofactor
(BH4) should be ruled out in all affected infants.
BH4 loading test. An oral dose of BH4 (20mg/kg) normalizes plasma phenylalanine in
patients with BH4 deficiency within 4–8hr.
Enzyme assay-The activity of Dihydropteridine Reductase can be measured in the dry blood
spots on the filter paper used for screening purposes. The other enzymes required for the
synthesis of BH4 can also be similarly estimated.
Figure-6- showing Guthrie card
Treatment
The goal of PKU treatment is to maintain the blood level of phenylalanine between 2 and 10
mg/dl. Some phenylalanine is needed for normal growth. This requires a diet that has some
phenylalanine but in much lower amounts than normal.
High protein foods, such as: meat, fish, poultry, eggs, cheese, milk, dried beans, and peas are
avoided. Instead, measured amounts of cereals, starches, fruits, and vegetables, along with a milk
substitute are usually recommended.
In some clinics, a phenylalanine ‘challenge’ may be suggested to evaluate whether or not the child
continues to require a low phenylalanine diet. This test identifies those few persons with a transient
or ‘variant’ form of the disorder.
No dietary restriction is currently recommended for infants whose phenylalanine levels are
between 2–6mg/dL. Plasma concentrations of phenylalanine in treated patients should be
maintained as close to normal as possible.
Because phenylalanine is not synthesized by the body, “over treatment” may lead to phenylalanine
deficiency manifested by lethargy, failure to thrive, anorexia, anemia, rashes, diarrhea, and even
death; moreover, tyrosine becomes an essential amino acid in this disorder and its adequate intake
must be ensured.
The current recommendation is that all patients be kept on a phenylalanine-restricted diet for life,
in order to promote maximal development and cognitive abilities.
Oral administration of the cofactor (BH4 ) to patients with milder forms
of hyperphenylalaninemia from phenylalanine hydroxylase deficiency may produce significant
reductions.
Glutamate- Central role in amino acid metabolism
Q.1- Justify the reasoning that glutamic acid plays a pivotal role in the metabolism of amino acids
Answer- Glutamate occupies a central place in amino acid metabolism. Basically it acts as a
collector of amino group of the amino acids. Free ammonia is toxic to the body especially to brain
cells, it is transported in the bound form to liver where it is finally detoxified forming urea.
Amino acids not needed as building blocks are degraded to specific compounds. The major site of
amino acid degradation in mammals is the liver. The amino group must be removed, in as much as
there are no nitrogenous compounds in energy-transduction pathways. Amino group can be
transferred (Transamination) or it can be removed in the form of ammonia (Deamination). The α-
keto acids that result from amino acids are metabolized so that the carbon skeletons can enter the
metabolic main stream as precursors to glucose or citric acid cycle intermediates.
The formation and fate of glutamate and significance of these processes related to metabolism of
amino acids can be explained as follows-
Sources of Glutamate include-
1) Transamination of amino acids
2) Hydrolysis of Glutamine
3) Metabolic product of amino acids
Fate of Glutamate
1) Oxidative deamination to from Alpha keto glutarate
2) Amination to form Glutamine
3) Decarboxylation to form GABA (Gamma amino butyric acid)
4) Formation of N-Acetyl Glutamate
All processes except GABA formation are involved in the catabolism of amino acids and transport
of amino group or ammonia.
1) Transamination and role of Glutamate
a) General reactions
Aminotransferases catalyze the transfer of an α-amino group from an α-amino acid to an α-keto
acid. These enzymes, also called transaminases, generally funnel α-amino groups from a variety of
amino acids to α-keto-glutarate for conversion into NH4 +(Figure-1)
Figure-1- showing the transfer of alpha amino group to an-α keto acid catalyzed by amino
transferase
The α -amino group of many amino acids is transferred to α -ketoglutarate to
form glutamate, which is then oxidatively deaminated to yield ammonium ion (NH4) (Figure-2)
Figure-2- showing the general role of glutamate in the transfer of amino group of amino acid that
can be subsequently removed as ammonium ion.
All the amino acids except lysine, threonine, proline, and hydroxyproline participate in
transamination. Transamination is readily reversible, and aminotransferases also function in amino
acid biosynthesis.
b) Special reactions
1) Aspartate aminotransferase, one of the most important of these enzymes, catalyzes the transfer
of the amino group of aspartate to α-ketoglutarate.
2) Alanine aminotransferase catalyzes the transfer of the amino group of alanine to α
-ketoglutarate.
Figure-3- Showing the oxidative deamination of Glutamate to from α- Keto glutarate. Glutamate
carries the amino group of amino acids from peripheral tissue to liver to be released as ammonium
ions .
The equilibrium for this reaction favors glutamate; the reaction is driven by the consumption of
ammonia. Glutamate dehydrogenase is located in mitochondria, as are some of the other enzymes
required for the production of urea. This compartmentalization sequesters free ammonia, which is
toxic.
The sum of the reactions catalyzed by aminotransferases and glutamate dehydrogenase is-
In most terrestrial vertebrates, NH4 + is converted into urea, which is excreted (Figure-4)
Figure-4-Showing the process of transdeamination and the role of glutamate
Role of Glutamate and Glutamate dehydrogenase- In majority of the transamination reactions
alpha keto glutarate is the acceptor keto acid forming Glutamate, that is oxidatively deaminated in
the liver by Glutamate dehydrogenase to form alpha keto glutarate and ammonia. Conversion of α-
amino nitrogen to ammonia by the concerted action of glutamate aminotransferase and GDH is
often termed “transdeamination.” Thus Transamination and deamination are coupled processes
though they occur at distant places and in these two processes Glutamate occupies the central
place.
Regulation of Glutamate dehydrogenase– The activity of glutamate dehydrogenase is allosterically
regulated. The enzyme consists of six identical subunits. Guanosine triphosphate (GTP) and
adenosine triphosphate (ATP) are allosteric inhibitors, whereas guanosine diphosphate (GDP) and
adenosine diphosphate (ADP) are allosteric activators. Hence, a lowering of the energy charge
(more of ADP and GDP) accelerates the oxidation of amino acids favoring formation of alpha keto
glutarate that can be channeled towards TCA cycle for complete oxidation to provide energy.
3) Glucose alanine cycle and the role of Glutamate- The transport of amino group of amino acids
also takes place in the form of Alanine.
Nitrogen is transported from muscle to the liver in two principal transport forms. Glutamate is
formed by transamination reactions, but the nitrogen is then transferred to pyruvate to form
alanine, which is released into the blood. The liver takes up the alanine and converts it back into
pyruvate by transamination. The pyruvate can be used for gluconeogenesis and the amino group
eventually appears as urea. This transport is referred to as the alanine cycle. It is reminiscent of the
Cori cycle and again illustrates the ability of the muscle to shift some of its metabolic burden to the
liver (Figure-5)
Figure-5- The Glucose- Alanine Cycle- Glutamate in muscle is transaminated to alanine, which is
released into the blood stream. In the liver, alanine is taken up and converted into pyruvate for
subsequent metabolism.
) Glutamate and Glutamine relationship
Ammonia Nitrogen can also be transported as glutamine. This is the first line of defense in brain
cells. Glutamine synthetase catalyzes the synthesis of glutamine from glutamate and NH4 + in an
ATP-dependent reaction (Figure-6)
Figure-9- Showing the role of N-Acetyl Glutamate as a positive modifier for CPS-1
6) Formation of GABA- GABA, an inhibitory neurotransmitter is produced from the decarboxylation
of glutamic acid by glutamate decarboxylase enzyme in the presence of B6-P (Figure-10)
Figure-10– showing the synthesis of GABA from glutamate.
Ammonia intoxication and role of glutamate- Excess of ammonia depletes glutamate and hence
GABA level in brain, To compensate for glutamate, alpha keto glutarate is used , the decrease
concentration of which subsequently depresses TCA and thus deprives brain cells of energy. Excess
Glutamine is exchanged with Tryptophan , a precursor of Serotonin , resulting in hyper excitation.
The symptoms of ammonia intoxication are all due to energy depletion and a state of
hyperexcitation.
Thus to conclude, Glutamate represents the major transporter of amino group of amino acids and
has a central role in both the catabolism of amino acids as well in the synthesis of non-
essential amino acids( through Transamination reactions).
Please help "Biochemistry for Medics" by CLICKING ON THE ADVERTISEMENTS above!
Posted in Metabolism - Proteins, Subjective Questions
Catecholamines- Synthesis, Degradation and Clinical Significance
Published December 16, 2012 | By Dr. Namrata Chhabra
Q.1- Alpha Methyl dopa is a drug used in the treatment of hypertension. Explain its possible mode
of action.
0r
Describe the steps of catecholamines synthesis and degradation and highlight the clinical
significance of these reactions.
Answer- Catecholamines are synthesized from Tyrosine.
Cells in the adrenal medulla synthesize and secrete epinephrine and nor epinephrine. In humans
80% of the catecholamine output is epinephrine.
Synthesis and Secretion of Catecholamines
Synthesis of catecholamines begins with the amino acid tyrosine, which is taken up by chromaffin
cells in the medulla and converted to norepinephrine and epinephrine through the following steps :
1) Tyrosine is hydroxylated to DOPA (Dihydroxy Phenyl Alanine) by Tyrosinase (Figure-1), that
requires BH4 (Tetra hydro biopterine) and NADPH. The reaction is similar to hydroxylation of phenyl
alanine to form Tyrosine. Tyrosinase meant for catecholamine synthesis is different for the one
required for Melanin synthesis.
2) Dopa decarboxylase, a Pyridoxal phosphate (B6-P)-dependent enzyme, forms dopamine by
decarboxylation of DOPA (Figure-1).
3) Subsequent hydroxylation of Dopamine by dopamine -β-oxidase then forms norepinephrine
(Figure-1). The enzyme requires molecular oxygen, vitamin C and Copper ion for its activity.
4) In the adrenal medulla, phenyl ethanolamine-N-methyltransferase utilizes S-adenosylmethionine
to methylate the primary amine of norepinephrine, forming epinephrine (Figure-1).
Figure-1- showing the steps of synthesis of Catecholamines
Norepinephrine and epinephrine are stored in electron-dense granules which also contain ATP and
several neuropeptides. Secretion of these hormones is stimulated by acetylcholine release from
preganglionic sympathetic fibers innervating the medulla. Many types of “stresses” stimulate such
secretion, including exercise, hypoglycemia and trauma. Following secretion into blood, the
catecholamines bind loosely to and are carried in the circulation by albumin and perhaps other
serum proteins.
Adrenergic Receptors and Mechanism of Action
These hormones bind adrenergic receptors on target cells, where they induce essentially the same
effects as direct sympathetic nervous stimulation. There are multiple receptor types which are
differentially expressed in different tissues and cells. The alpha and beta adrenergic receptors and
their subtypes were originally defined by differential binding of various agonists and antagonists
and, more recently, by analysis of molecular clones.
Physiologic Effects of Medullary Hormones
In general, circulating epinephrine and norepinephrine released from the adrenal medulla have the
same effects on target organs as direct stimulation by sympathetic nerves, although their effect is
longer lasting. Additionally, of course, circulating hormones can cause effects in cells and tissues
that are not directly innervated. The physiologic consequences of medullary catecholamine release
are justifiably framed as responses which aid in dealing with stress. A listing of some major effects
mediated by epinephrine and norepinephrine are:
Increased rate and force of contraction of the heart muscle: this is predominantly an effect
of epinephrine acting through beta receptors.
Constriction of blood vessels: norepinephrine, in particular, causes widespread
vasoconstriction, resulting in increased resistance and hence arterial blood pressure.
Dilation of bronchioles: assists in pulmonary ventilation.
Stimulation of lipolysis in fat cells: this provides fatty acids for energy production in many
tissues and aids in conservation of dwindling reserves of blood glucose.
Increased metabolic rate: oxygen consumption and heat production increase throughout
the body in response to epinephrine. Medullary hormones also promote breakdown of
glycogen in skeletal muscle to provide glucose for energy production.
Dilation of the pupils: particularly important under conditions of low ambient light.
Inhibition of certain “non-essential” processes: an example is inhibition of gastrointestinal
secretion and motor activity.
Common stimuli for secretion of adrenomedullary hormones include exercise, hypoglycemia,
hemorrhage and emotional distress. The alpha and Beta blockers are used as drugs to inhibit the
action of catecholamines.
Catecholamine degradation
Catecholamines are degraded in the liver by two enzymes, COMT( Catechol-O-Methyl-Transferase)
and MAO(Mono amine Oxidase). By the action of COMT, epinephrine and Nor epinephrine are
converted to metanephrine and nor metanephrine respectively. Both these products are further
acted upon by MAO to form VMA (Vanillyl Mandelic acid) and MOPG (3-Methoxy 4-
hydroxyphenylglycol). These products are further excreted in urine. Epinephrine and nor epinephrine
can be acted upon directly also by MAO to form DOPG and DOMA (Figure-2).The Excretory products
are increased in Pheochromocytoma and that forms the basis for the diagnostic test.
Figure-2- showing the steps of degradation of Catecholamines
Clinical Significance-
Methyldopa (L-α-Methyl-3,4-dihydroxyphenylalanine; Aldomet, Aldoril, Dopamet, Dopegyt, etc.) is
a drug used as a sympatholytic or antihypertensive agent . It is less commonly used now following
the introduction of alternative safer classes of agents. However, it continues to have a role in
otherwise difficult to treat hypertension and gestational hypertension (also known as pregnancy-
induced hypertension (PIH)) and pre eclampsia.
Mechanism of action- Methyldopa has a dual mechanism of action:
It is a competitive inhibitor of the enzyme DOPA decarboxylase, also known as aromatic L-
amino acid decarboxylase, which converts L-DOPA into dopamine. This inhibition results in
reduced dopaminergic and adrenergic neurotransmission in the peripheral nervous system.
This effect may lower blood pressure and cause central nervous system effects such
as depression, anxiety, apathy, and parkinsonism.
It is converted to α-methylnorepinephrine by dopamine beta-hydroxylase (DBH). α-
methylnorepinephrine is an agonist of presynaptic central nervous system α2-
adrenergic receptors. Activation of these receptors in the brainstem appears to
inhibit sympathetic nervous system output and lower blood pressure.
Figure-1- showing the transfer of amino group from a donor amino acid to a keto acid for the
formation of a new amino acid and a new keto acid
The general process of transamination is reversible and is catalyzed by a transaminase, also called
amino transferase that require B6-Phosphate as a coenzyme.
Most of the amino acids act as substrate for the transaminases but the amino acids like lysine,
threonine, proline, and hydroxyproline do not participate in transamination reactions.
Transamination is not restricted to α -amino groups. The δ-amino group of ornithine and the ε-
amino group of lysine—readily undergoes transamination.
Role of B6 Phosphate as a coenzyme
The coenzyme pyridoxal phosphate (PLP) is present at the catalytic site of aminotransferases and
of many other enzymes that act on amino acids. PLP, is a derivative of vitamin B6 (Figure-2).
Figure-2- Showing the structure of B6-Phosphate
1) B6-P forms an enzyme-bound Schiff base intermediate that can rearrange in various ways-
Figure-3-In the “resting” state, the aldehyde group of pyridoxal phosphate is in a Schiff base
linkage to the ε-amino group of an enzyme lysine side-chain.
2) During transamination, bound PLP serves as a carrier of amino groups (Figure-5 and 6)
3) Rearrangement forms an α -keto acid and enzyme-bound Pyridoxamine phosphate(Figure-4, 5
and 6), which forms a Schiff base with a second keto acid (Figure-5).
Figure-4-The α-amino group of a substrate amino acid displaces the enzyme lysine, to form a Schiff
base linkage to PLP.
Figure-5- A different a-keto acid reacts with PMP (Pyridoxamine phosphate) and the
process reverses, to complete the reaction.
Figure-6 -Overall reaction showing the role of B6-Phosphate, the transfer of α-amino group from
donor amino acid to Pyridoxal phosphate forms Pyridoxamine phosphate, and a keto acid. The α-
amino group is finally passed on to an acceptor an α-keto acid to form a new amino acid.
Significance of Transamination – Transamination is used both for the catabolic as well as anabolic
processes. The resultant α-Keto acid can be completely oxidized to provide energy, glucose, fats or
ketone bodies depending upon the cellular requirement. Since it is a reversible process, it is also
used or the synthesis of non-essential amino acids. Some points of significance are as follows-
Once the keto acids have been formed from the appropriate amino acids by
transamination, they may be used for several purposes. The most obvious is the complete
metabolism into carbon dioxide and water by the citric acid cycle.
However, if there are excess proteins in the diet those amino acids that are converted into
pyruvic acid and acetyl CoA can be converted into lipids by the lipogenesis process. If
carbohydrates are lacking in the diet or if glucose cannot get into the cells (as in diabetes),
then those amino acids converted into pyruvic acid and oxaloacetic acids can be converted
into glucose or glycogen.
The most usual and major keto acid involved with transamination reactions is alpha-
ketoglutaric acid, an intermediate in the citric acid cycle.
All of the amino acids can be converted through a variety of reactions and transamination
into a keto acid which is a part of or feeds into the citric acid cycle.
In addition to the catabolic function of transamination reactions, these reactions can also
be used to synthesize amino acids needed or not present in the diet. An amino acid may be
synthesized if there is an available “root” keto acid with a synthetic connection to the final
amino acid. Since an appropriate “root” keto acid does not exist for eight amino acids, (lys,
leu, ile, met, thr, try, val, phe), they are essential and must be included in the diet because
they cannot be synthesized. Transaminases equilibrate amino groups among available α-
keto acids. This permits synthesis of non-essential amino acids, using amino groups derived
from other amino acids and carbon skeletons synthesized in the cell. Thus a balance of
different amino acids is maintained, as proteins of varied amino acid contents are
synthesized.
Glutamic acid usually serves as the source of the amino group in the transamination
synthesis of new amino acids. The reverse of the reactions are the most obvious methods
for producing the amino acids alanine and aspartic acid.
In addition to equilibrating amino groups among available α-keto acids,
transaminases funnel amino groups from excess dietary amino acids to those amino acids
(e.g., glutamate) that can be deaminated. Carbon skeletons of deaminated amino acids can
be catabolized for energy or used to synthesize glucose or fatty acids for energy storage.
Figure-7 – Glutamate is the ultimate collector of amino groups of amino acids, In the liver it is
rapidly deaminated, ammonia thus released is detoxified by forming urea
Q.- Discuss the clinical significance of transaminases.
Answer– The enzymes catalyzing transamination process exist for all amino acids except threonine
and lysine. The most common compounds involved as a donor/acceptor pair in transamination
reactions are glutamate and α-ketoglutarate ( α-KG), which participate in reactions with many
different aminotransferases. Serum aminotransferases such as serum glutamate-oxaloacetate-
aminotransferase (SGOT) (also called aspartate aminotransferase, AST) and serum glutamate-
pyruvate aminotransferase (SGPT) (also called alanine transaminase, ALT) have been used as
clinical markers of tissue damage, with increasing serum levels indicating an increased extent of
damage.
1) AST is found in the liver, cardiac muscle, skeletal muscle, kidneys, brain, pancreas, lungs,
leukocytes, and erythrocytes in decreasing order of concentration.
Reaction catalyzed can be represented as follows-
Q.1- Which of the following is a common compound shared by the TCA cycle and the Urea cycle?
a) α- Keto glutarate
b) Succinyl co A
c) Oxalo acetate
d) Fumarate
Q.2-Which of the followings is a common nitrogen acceptor for all reactions involving
transaminases?
a) α- Keto glutarate
b) Pyruvate
c) Oxaloacetate
d) Acetoacetate
Q.3- In a 55- year-old man, who has been diagnosed with cirrhosis of liver, Ammonia is not getting
detoxified and can damage brain. Which of the following amino acids can covalently bind
ammonia, transport and store in a non toxic form?
a) Aspartate
b) Glutamate
c) Serine
d) Cysteine
Q.4- In a new born presenting with refusal to feeds and irritability, a deficiency of Cystathionine –β–
synthase has been diagnosed, which of the following compounds is expected to be elevated in
blood?
a) Serine
b) Glutamate
c) Homocysteine
d) Valine
Q.5 -A 3- month-old child is being evaluated for vomiting and an episode of convulsions, Laboratory
results show hyperammonemia and Orotic aciduria. Which of the following enzyme defect is likely
to be there?
a) Glutaminase
b) Arginase
c) Argino succinic acid synthase
d) Ornithine Transcarbamoylase
Q.6- Which out of the following amino acids is not converted to Succinyl co A?
a) Methionine
b) Valine
c) Isoleucine
d) Histidine
Q.7-All of the following compounds are synthesized by transmethylation reactions, except-
a) Choline
b) Epinephrine
c) Creatine
d) Ethanolamine
Q.8- A patient diagnosed with Hart Nup disease, (due to deficiency of transporter required for the
absorption of amino acid tryptophan), has been brought with skin rashes and suicidal tendencies.
Tryptophan is a precursor for many compounds, the deficiencies of which can cause the said
symptoms. Which out of the following compounds is not synthesized by tryptophan?
a) Serotonin
b) Epinephrine
c) Melatonin
d) Niacin
Q.9- Histamine, a chemical mediator of allergies and anaphylaxis, is synthesized from amino acid
Histidine by which of the following processes?
a) Deamination
b) Decarboxylation
c) Transamination
d) Dehydrogenation
Q.10- The synthesis of all of the following compounds except one is deficient in a patient suffering
from Phenylketonuria-
a) Melanin
b) Melatonin
c) Catecholamines
d) Thyroid hormone
Q.11- The diet of a child suffering from Maple syrup urine disease (an amino acid disorder), should
be low, in which out of the following amino acids content?
a) Branched chain amino acids
b) Phenylalanine Alanine
c) Methionine
d) Tryptophan
Q.12- Which out of the following amino acids in not required for creatine synthesis?
a) Methionine
b) Serine
c) Glycine
d) Arginine
Q.13- All of the following substances are synthesized from Cysteine, except-
a) Taurine
b) Mercaptoethanolamine
c) Melanin
d) Pyruvate
Q.14- Urea is synthesized in –
a) Cytoplasm
b) Mitochondria
c) Both cytoplasm and mitochondria
d) In lysosomes
Q.15-Blood urea decreases in all of the following conditions, except-
a) Liver cirrhosis
b) Pregnancy
c) Renal failure
d) Urea cycle disorders
Q.16- All of the following amino acids are donors of one carbon compounds except-
a) Histidine
b) Tyrosine
c) Tryptophan
d) Serine
Q.17- The two nitrogen of urea are derived from-
a) Aspartate and Ammonia
b) Glutamate and ammonia
c) Argino succinate and ammonia
d) Alanine and ammonia
Q.18- Which out of the following amino acids is not required for the synthesis of Glutathione?
a) Serine
b) Cysteine
c) Glutamic acid
d) Glycine
Q.19- The first line of defence in brain in conditions of hyperammonemia is-
a) Urea formation
b) Glutamine synthesis
c) Glutamate synthesis
d) Asparagine formation
Q.20- Which coenzyme out of the followings is required for the oxidative deamination of most of
amino acids?
a) Folic acid
b) Pyridoxal- P
c) FMN
d) FAD
Q.21-Chose the incorrect statement about amino acid Glycine-
a) One carbon donor
b) Required for the synthesis of haem
c) Forms oxalates upon catabolism
d) Both glucogenic as well as ketogenic
Q.22- Which out of the followings is required as a coenzyme for the transamination reactions?
a) Coenzyme A
b) Pyridoxal-P
c) Folic acid
d) Cobalamine
Q.23- A patient diagnosed with Homocystinuria should be supplemented with all of the following
vitamins except-
a) Vitamin C
b) Folic acid
c) Vitamin B12
d) Pyridoxal- P
Q.24- In a patient suffering from Cystinuria, which out of the following amino acids is not seen in
urine of affected patients?
a) Arginine
b) Methionine
c) Lysine
d) Ornithine
Q.25- Positive nitrogen balance is seen in all of the following conditions except-
a) Pregnancy
b) Growth
c) Fever
d) Convalescence
Q.26- The L-amino acids are absorbed from intestine by-
a) Active transport
b) Passive diffusion
c) Pinocytosis
d) Facilitated diffusion
Q.27- A child presented with increased frequency of urination, photophobia and impairment of
vision. Which out of the following defects could be responsible for the said symptoms?
a) Tyrosinosis
b) Cystinosis
c) Alkaptonuria
d) Albinism
Q.28- Which out of the following statements about Glutamate dehydrogenase is correct?
a) Required for transamination reactions
b) Universally present in all the cells of the body
c) Can utilize either of NAD+ /NADP+
d) Catalyzes conversion of glutamate to glutamine
Q.-29-A child was brought to paediatric OPD with complaint of passage of black colored urine. A
disorder of Phenylalanine metabolism was diagnosed. A low phenylalanine diet and a
supplementation of vitamin C were recommended. Which enzyme defect is expected in this child?
a) Phenyl alanine hydroxylase
b) Tyrosine transaminase
c) Homogentisic acid oxidase
d) Hydrolase
Q.30- Dopamine is synthesized from which of the following amino acids?
a) Tyrosine
b) Tryptophan
c) Histidine
d) Methionine
Q.31- In mammalian tissue serine can be a biosynthetic precursor for which amino acid?
a) Methionine
b) Glycine
c) Arginine
d) Lysine
Q.32- Hydroxylation of Phenyl Alanine to Tyrosine requires all except
a) Glutathione
b) Tetra hydrobiopterin
c) Molecular oxygen
d) NADPH
Q.33- The amino acid that undergoes oxidative deamination at a highest rate is-
a) Glutamine
b) Glutamate
c) Aspartate
d) Alanine
Q.34- All of the following statements regarding serotonin are true except-
a) Causes vasodilatation
b) Causes broncho constriction
c) Metabolized to 5-hydroxy Indole acetic acid
d) Causes diarrhoea
Q.35- Choose the incorrect statement about cysteine-
a) Carbon skeleton is provided by serine
b) Sulfur group is provided by Methionine
c) Forms Hippuric acid for detoxification of xenobiotics
d) Required for Bile salt formation
Answers-
1) – d, 2) – a, 3) – b, 4) -c, 5) – d, 6) – d, 7) – d, 8) – b, 9) – b, 10) – b, 11) – a), 12) – b, 13) – c, 14)
– c, 15) – c,16) – b, 17) – a, 18) – a,
19) – b, 20) – c, 21) – d, 22) – b,23) -a, 24)- b, 25) – c, 26) – a, 27) – b, 28) – c, 29) – c, 30) –
a, 31) – b,32) – a, 33) – b, 34) – a,35) – c.